| 今开：69.72 | 昨收：71.01 |
| 最高：71.635 | 最低：68.61 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.517985425E9 |
Intra-cellular(ITCI)02-10 01:45
$Intra-cellular(ITCI)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-24-000021 Act: 34 Size: 4 KB 网页链接查看全文
Intra-cellular(ITCI)02-09 22:25
$Intra-cellular(ITCI)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001226 Act: 34 Size: 8 KB 网页链接查看全文
Intra-cellular(ITCI)02-27 06:05
$Intra-cellular(ITCI)$ 144 Report of proposed sale of securities Accession Number: 0002007317-24-000215 Act: 33 Size: 4 KB 网页链接查看全文
Intra-cellular(ITCI)03-06 08:05
$Intra-cellular(ITCI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026529 Size: 5 KB 网页链接查看全文
Intra-cellular(ITCI)03-06 08:05
$Intra-cellular(ITCI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026536 Size: 5 KB 网页链接查看全文
Intra-cellular(ITCI)03-06 08:15
$Intra-cellular(ITCI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026539 Size: 5 KB 网页链接查看全文
Intra-cellular(ITCI)03-09 07:05
$Intra-cellular(ITCI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028820 Size: 7 KB 网页链接查看全文
Intra-cellular(ITCI)02-22 20:45
$Intra-cellular(ITCI)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001193125-24-042106 Act: 34 Size: 262 KB 网页链接查看全文
Intra-cellular(ITCI)03-12 04:55
$Intra-cellular(ITCI)$ 144 Report of proposed sale of securities Accession Number: 0002007317-24-000382 Act: 33 Size: 6 KB 网页链接查看全文
chuminhua04-17 16:24
4/16，Intra-Cellular Therapies $Intra-cellular(ITCI)$ 周二表示，针对重度抑郁症 (MDD) 患者进行的 Caplyta (lumateperone) 的 III 期研究达到了主要终点和关键次要终点，使该药物距离获得更广泛的适应症批准又近了一步。 该消息推动公司股价上涨近28%。
首席医疗官 Suresh Durgam 表示：“...查看全文
逍遥投资派2023-05-20 23:09
$Intra-cellular(ITCI)$ 2020年开始产生比较有意义的营收后连续大幅增长，2022年达到2.5亿，营业利润和净利润反而亏损加大，目前看不到投资价值。查看全文
chuminhua2023-03-29 17:00
3月28日，Intra-Cellular Therapies $Intra-cellular(ITCI)$ 报告称，Caplyta（lumateperone）有助于显著降低重度抑郁症（MDD）混合特征患者和双相抑郁症混合特征患者的抑郁症状严重程度。 消息传出后，公司股价上涨了 15%。
研究 403 旨在评估非典型抗精神病药物作为单一疗法治疗与 MDD 或双...查看全文
SeekingBiotech2023-03-28 23:59
$Intra-cellular(ITCI)$
ITCI Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with MDD with Mixed Features and Bipolar Depression with Mixed Features #CNS#查看全文
美股滚雪球2022-07-22 14:13
CNS药物领域不错的公司：$Xenon制药(XENE)$ &$Intra-cellular(ITCI)$ 被收购的概率比较大。
$恒瑞医药(SH600276)$查看全文
产业链观察2021-12-20 19:56
药闻| 2021年12月20日，专注于中枢神经系统（CNS）疾病疗法开发和商业化的生物制药公司$Intra-cellular(ITCI)$ 今天宣布美国食品和药物管理局（FDA）批准CAPLYTA用于治疗与成人双相I型或II型疾病相关的抑郁症发作，可作为单药治疗，也可作为锂或丙戊酸钠的辅助治疗。查看全文
啊韭的Biotech2021-10-09 03:45
接上一篇：网页链接
$Biogen制药(BIIB)$ (Sector Perform, PT $325)： Aduhelm在争议中获批，但其销量也远低预期（est. $5.5M vs. $16M cons.）。同时，另一款治疗阿尔茨海默症的药物 – lenacanemab – 正在获得越来越多的兴趣。处方数据显示公司三季度营收...查看全文
$INTRA CELLULAR THERAPIES INC(ITCI)$ 8-K - Current report Filed: 2016-06-30 AccNo: 0001193125-16-637457 Size: 26 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ 8-K - Current report Filed: 2016-06-28 AccNo: 0001193125-16-633711 Size: 26 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ 8-K - Current report Filed: 2016-06-15 AccNo: 0001193125-16-622466 Size: 21 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ 美东时间 2016-06-21 15:00 Intra-Cellular Therapies Inc at JMP Securities Life Sciences Conference 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-05-03 AccNo: 0001193125-16-575025 Size: 693 KB 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-28 AccNo: 0001193125-16-564211 Size: 987 KB 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ 8-K - Current report Filed: 2016-04-28 AccNo: 0001193125-16-561029 Size: 65 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-04-28 AccNo: 0001193125-16-563851 Size: 2 MB 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ 美东时间 2016-04-28 08:30 Q1 2016 Intra-Cellular Therapies Inc Earnings Call 网页链接
$INTRA CELLULAR THERAPIES INC(ITCI)$ 美东时间 2016-04-28 09:00 Before Open:INTRA-CELLULAR Earning Release . Wall St EPS Est ($):-0.75. 网页链接